StockData
Sigyn Therapeutics, Inc. logo

Sigyn Therapeutics, Inc. (SIGY) stock

SIGYOTCSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Số liệu tài chính tới Q3 năm tài chính 2025, quý kết thúc ngày Sep 30, 2025Last filing: 10-Q on Nov 14, 2025Score 0/30
$0.03+0.00 (0.00%)

Close on Oct 19, 2026Market cap $48.16KP/E –Yield –

What it earns on the capital it uses

Trailing twelve months over average capital

Return on assets-1144.2%vs -12.2%

How hard the assets work

Profit per employee-$805.27Kvs -$48.85K

The grey tick and the second figure are the median of companies in the same industry group; green means this company is on the better side of it.

What it owes and what covers it

Latest balance sheet, against twelve months of cash generation

Borrowings exceed cash by $3.00M.

Total debt$3.09M
Cash and short-term investments$85.57K
EBITDA, trailing twelve months-$1.88M

Leverage and liquidity

Current ratio0.02vs 2.50
Quick ratio0.02vs 1.55

The grey tick and the second figure are the median of companies in the same industry group; green means this company is on the better side of it.

Scores and rules of thumb

Academic scores computed from the latest two fiscal years. They are screens, not verdicts.

Piotroski F-Score

Nine yes-or-no tests of profit, leverage and efficiency against last year.

3 of 9 tests passed

How the shares have traded

Total return includes reinvested dividends, to the close on Oct 19, 2026

Total return against the S&P 500

The axis is compressed: each step is ten times the one before, so a month and a decade fit on the same line.

SIGYS&P 500
PeriodSIGYS&P 500DifferenceSIGY per yearS&P 500 per year
1 month-13.8%+0.6%−14.4 pts
3 months-25.0%+3.4%−28.4 pts
Year to date-98.2%+13.3%−111.5 pts
1 year-98.5%+16.6%−115.1 pts
3 years-99.7%+86.4%−186.0 pts-84.9%+23.1%
5 years-99.8%+81.9%−181.7 pts-72.3%+12.7%

Who is betting against it

Shares sold short and not yet covered, reported by brokers to FINRA twice a month. Latest settlement date Oct 15, 2026.

0M SIGY shares were sold short on Oct 15, 2026. At recent volumes it would take 1.0 days to buy them back.

Shares sold shortDays to cover

The last twelve reports

Settlement dateShares shortChangeAvg. daily volumeDays to cover
Oct 15, 20261,994–13,9551.0
Jul 15, 20261,501-78.8%118,7471.0
Jun 30, 20267,095-54.5%10,4381.0
Jun 15, 202615,577-51.9%23,9911.0
May 29, 202632,362+1083.3%54,1951.0
May 15, 20262,735-86.4%70,3701.0
Apr 30, 202620,045+660.7%242,6851.0
Apr 15, 20262,6350.0%147,6161.0
Mar 31, 20262,635-91.0%618,0341.0
Mar 13, 202629,321+30764.2%328,6531.0
Feb 27, 2026950.0%45,7011.0
Feb 13, 2026950.0%4001.0

Every measure, in full

26 figures from SEC filings and the closing price. Hover a name for the formula; the last column is the median of companies in the same industry group.

Important dates

Next earnings
–
Last ex-dividend date
No dividends
Fundamentals through
Sep 30, 2025
Share price as of
–

Share statisticsIndustry

Shares Change (YoY)
28.5%
3.51%
Shares Change (QoQ)
0.00%
0.31%
Float
2M
38M
Shares Held by Insiders
0.00%
10.4%
Shares Held by Institutions
3.30%
60.2%

Returns on capitalIndustry

Return on Assets (ROA)
-1144.2%
-12.2%

Financial positionIndustry

Current Ratio
0.02
2.50
Quick Ratio
0.02
1.55

EfficiencyIndustry

Profits Per Employee
-$805.27K
-$48.85K
Employee Count
4
193

Income statement (TTM)Industry

Operating Income
-$1.88M
-$3.82M
Pretax Income
-$3.22M
-$2.12M
Net Income
-$3.22M
-$6.19M
EBITDA
-$1.88M
-$2.02M
EPS (Diluted)
-$2.01
-$0.08

Balance sheetIndustry

Total Debt
$3.09M
$99.39M
Net Cash (Debt)
-$3.00M
$3.73M
Net Cash Per Share
-$1.87
$0.28
Equity (Book Value)
-$5.92M
$63.83M
Book Value Per Share
-$3.69
$2.98
Tangible Book Value
-$5.92M
$10.75M
Working Capital
-$3.90M
$57.32M

Cash flow (TTM)Industry

Operating Cash Flow
-$936.43K
-$463.66K

Scores and fair valueIndustry

Piotroski F-Score
3
5

Ratios use trailing-twelve-month results and the latest balance sheet. How we calculate.

See a number that looks wrong?